Russell Investments Group Ltd. Cuts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Russell Investments Group Ltd. decreased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 666,314 shares of the medical instruments supplier's stock after selling 47,935 shares during the quarter. Russell Investments Group Ltd. owned about 0.34% of DENTSPLY SIRONA worth $12,647,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter worth about $26,000. MassMutual Private Wealth & Trust FSB boosted its position in shares of DENTSPLY SIRONA by 648.4% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after buying an additional 1,232 shares during the period. UMB Bank n.a. grew its stake in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after buying an additional 564 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of DENTSPLY SIRONA by 700.0% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after buying an additional 1,568 shares during the period. Finally, Signaturefd LLC lifted its stake in shares of DENTSPLY SIRONA by 513.3% during the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock worth $84,000 after acquiring an additional 3,706 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

Several research firms have recently weighed in on XRAY. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. Evercore ISI reiterated an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. StockNews.com lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a report on Tuesday. Finally, Robert W. Baird dropped their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a report on Friday, February 28th. Thirteen equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has an average rating of "Hold" and a consensus price target of $22.58.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.52% of the stock is owned by insiders.

DENTSPLY SIRONA Stock Down 3.9 %

Shares of NASDAQ XRAY traded down $0.51 during midday trading on Tuesday, hitting $12.57. The company's stock had a trading volume of 1,744,622 shares, compared to its average volume of 2,944,405. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market capitalization of $2.50 billion, a price-to-earnings ratio of -6.07, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The business's fifty day simple moving average is $16.09 and its two-hundred day simple moving average is $19.01. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $31.75.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 5.09%. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.